Pridopidine, a selective Sigma-1 receptor (S1R) agonist promotes neuroprotection in ALS models

被引：0
|
作者：
Geva, Michal [1 ]
Wang, Shao-Ming [2 ,3 ,5 ]
Wu, Hsiang-En [2 ,4 ]
Ankol, Lior [6 ,7 ]
Ionescu, Ariel [6 ,7 ]
Gradus-Pery, Tal [6 ,7 ]
Gershoni-Emek, Noga [1 ]
Goldberg, Y. Paul [1 ]
Su, Tsung-Ping [2 ]
Perlson, Eran [6 ,7 ]
Hayden, Michael R. [1 ,8 ]
机构：
[1] Prilenia Therapeut, Herzliyya, Israel
[2] Natl Inst Drug Abuse, Natl Inst Hlth, Cellular Pathobiol Sect, Integrat Neurosci Res Branch,Intramural Res Progr, Baltimore, MD USA
[3] China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan
[4] China Med Univ, Neurosci & Brain Dis Ctr, Taichung, Taiwan
[5] China Med Univ Hosp, Dept Neurol, Taichung, Taiwan
[6] Sagol Sch Neurosci, Tel Aviv, Israel
[7] Sackler Sch Med, Tel Aviv, Israel
[8] Univ British Columbia, CMMT, Vancouver, BC, Canada
来源：
MUSCLE & NERVE | 2022年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
6
引用
收藏
页码：S4 / S5
页数：2
相关论文
共 50 条
  • [41] Sigma-1 receptor agonist fluvoxamine for delirium in older adults
    Hashimoto, Kenji
    Furuse, Tsutomu
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2012, 27 (09) : 981 - 983
  • [42] Can the Sigma-1 Receptor Agonist Fluvoxamine Prevent Schizophrenia?
    Hashimoto, Kenji
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2009, 8 (06) : 470 - 474
  • [43] Sigma-1 receptor and neuroprotection:current outlook and potential therapeutic effects
    Giovanni Li Volti
    Paolo Murabito
    Neural Regeneration Research, 2016, 11 (09) : 1392 - 1393
  • [44] PRIDOPIDINE EXERTS BENEFICIAL EFFECTS IN PRECLINICAL MODELS AND IN CLINICAL TRIALS VIA ACTIVATION OF THE SIGMA-1 RECEPTOR, IN A BIPHASIC MANNER
    Geva, Michal
    Abdulhayoglu, Deniz Akinc
    Wang, Shao-Ming
    Gershoni-Emek, Noga
    Boulanger, Bruno
    Goldberg, Y. Paul
    Su, Tsung-Ping
    Hayden, Michael R.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2022, 93 : A98 - A98
  • [45] Sigma-1 receptor and neuroprotection: current outlook and potential therapeutic effects
    Volti, Giovanni Li
    Murabito, Paolo
    NEURAL REGENERATION RESEARCH, 2016, 11 (09) : 1392 - 1393
  • [46] Selective sigma-1 receptor antagonists for the treatment of pain
    Almansa, Carmen
    Miguel Vela, Jose
    FUTURE MEDICINAL CHEMISTRY, 2014, 6 (10) : 1179 - 1199
  • [47] Pridopidine protects neurons from mutant-huntingtin toxicity via the sigma-1 receptor
    Eddings, Chelsy R.
    Arbez, Nicolas
    Akimov, Sergey
    Geva, Michal
    Hayden, Michael R.
    Ross, Christopher A.
    NEUROBIOLOGY OF DISEASE, 2019, 129 : 118 - 129
  • [48] SELECTIVE SIGMA-1 RECEPTOR (σ1R) ANTAGONISTS: AN EMERGING TARGET FOR THE TREATMENT OF NEUROPATHIC PAIN
    Diaz Fernandez, Jose Luis
    DRUGS OF THE FUTURE, 2009, 34 : 18 - 19
  • [49] The Renoprotective Effect Of Sigma-1 Receptor Agonist In Ischemia/reperfusion Injury
    Hodrea, Judit
    Hosszu, Adam
    Antal, Zsuzsanna
    Koszegi, Sandor
    Banki, Nora Fanni
    Wagner, Laszlo
    Lenart, Lilla
    Vannay, Adam
    Szabo, Attila J.
    Fekete, Andrea
    PEDIATRIC NEPHROLOGY, 2014, 29 (09) : 1670 - 1670
  • [50] Cognition and depression: the effects of fluvoxamine, a sigma-1 receptor agonist, reconsidered
    Hindmarch, Ian
    Hashimoto, Kenji
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2010, 25 (03) : 193 - 200
12345